截至(zhi)收盤，恒生(sheng)港股通創(chuang)新藥(yao)(yao)(yao)指(zhi)(zhi)數(shu)下跌(die)(die)3.2%，中(zhong)證(zheng)港股通醫(yi)藥(yao)(yao)(yao)衛生(sheng)綜合指(zhi)(zhi)數(shu)下跌(die)(die)2.6%，中(zhong)證(zheng)創(chuang)新藥(yao)(yao)(yao)產(chan)業(ye)指(zhi)(zhi)數(shu)、中(zhong)證(zheng)生(sheng)物科技(ji)主(zhu)題指(zhi)(zhi)數(shu)均上(shang)(shang)漲0.3%，滬深300醫(yi)藥(yao)(yao)(yao)衛生(sheng)指(zhi)(zhi)數(shu)上(shang)(shang)漲1.1%。據(ju)(ju)Wind數(shu)據(ju)(ju)，恒生(sheng)創(chuang)新藥(yao)(yao)(yao)ETF（159316）今日(ri)獲6900萬(wan)份(fen)凈申購，截至(zhi)昨日(ri)，該產(chan)品近(jin)一(yi)個月“吸金”約(yue)7億元，最新規模(mo)達14.5億元、創(chuang)歷(li)史(shi)新高。